Skip to content
PEPLUX
Illustrative PEPLUX product vial in a purple-lit studio
Product illustration

Informational listing

Tesamorelin

Compounded tesamorelin does not lawfully exist: tesamorelin is regulated as a biological product, and compounding pharmacies have no pathway to make it.

FDA status

Cannot be compounded.

Checked on October 13, 2026.

This page provides product and regulatory information. Ordering is not available for this product.

Review the FDA status

This information is educational and is not medical advice. It does not establish a provider–patient relationship.

Know your options

FDA status for Tesamorelin.

Each record below links to the primary sources and shows when the information was last checked.

Tesamorelin

Cannot be compounded.

Tesamorelin is a biological product, and federal law gives compounding pharmacies and outsourcing facilities no pathway to make it. A branded tesamorelin product is licensed for one labeled use, the reduction of excess abdominal fat in adults with HIV who have lipodystrophy, and it is not for weight loss. Compounded tesamorelin is not that product and is not FDA-approved.

View the full FDA status record

Primary sources

  1. FDAList of approved NDAs for biological products that were deemed to be BLAs on March 23, 2020 (corrected April 2, 2020)Document dated . Checked .
  2. FDACompounding and the FDA: Questions and AnswersDocument dated . Checked .
  3. FDA labelopenFDA drug labels: tesamorelin, BLA 022505 (EGRIFTA SV and EGRIFTA WR)Document dated . Checked .
  4. FDAopenFDA drugsfda: tesamorelin, BLA 022505Document dated . Checked .
  5. FDA warning letterWarning letter 734884, Royal Peptides LLCDocument dated . Checked .
  6. FDA warning letterWarning letter 735063, Peptide Partners LLCDocument dated . Checked .
  7. WADAWorld Anti-Doping Code, 2026 Prohibited ListDocument dated . Checked .
Back to the collection